PMC:7048180 / 9397-9569 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T46","span":{"begin":63,"end":71},"obj":"Disease"}],"attributes":[{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"These results suggest that CR3022, distinct from the other two SARS-CoV antibodies, recognizes an epitope that does not overlap with the ACE2 binding site of 2019-nCoV RBD."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T50","span":{"begin":98,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_53000"}],"text":"These results suggest that CR3022, distinct from the other two SARS-CoV antibodies, recognizes an epitope that does not overlap with the ACE2 binding site of 2019-nCoV RBD."}

{"project":"LitCovid-sentences","denotations":[{"id":"T58","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These results suggest that CR3022, distinct from the other two SARS-CoV antibodies, recognizes an epitope that does not overlap with the ACE2 binding site of 2019-nCoV RBD."}

{"project":"LitCovid-PubTator","denotations":[{"id":"321","span":{"begin":137,"end":141},"obj":"Gene"},{"id":"329","span":{"begin":158,"end":167},"obj":"Species"},{"id":"331","span":{"begin":63,"end":71},"obj":"Species"},{"id":"337","span":{"begin":27,"end":33},"obj":"Chemical"}],"attributes":[{"id":"A321","pred":"tao:has_database_id","subj":"321","obj":"Gene:59272"},{"id":"A329","pred":"tao:has_database_id","subj":"329","obj":"Tax:2697049"},{"id":"A331","pred":"tao:has_database_id","subj":"331","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These results suggest that CR3022, distinct from the other two SARS-CoV antibodies, recognizes an epitope that does not overlap with the ACE2 binding site of 2019-nCoV RBD."}